-
The Avandia Heart Attack Risk Was Raised To FDA Back In 2000; Will Agency Wait Until 2009 To Act?
In Comparison, Europe’s Regulators Had Glaxo Change Avandia Label In 2006 To Include Warning About Risk Of Cardiac Ischemic Events Such As Heart Attacks (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 24,…
-
Glaxo’s Diabetes Drug Avandia May Cause Significant Heart Attack Risk
Avandia Might Have Prevented Diabetes In Some Patients, But Is This Benefit Offset By The Risk Of Heart Problems? (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2007 the Los Angeles Times published…
-
Merck’s May 2007 Report On Vioxx Trial Dates For Next Nine Months
Vioxx Trials Scheduled In CA, AL, FL, NV, WV, TX, and IL State Courts As Well As Federal Court MDL (Posted by Tom Lamb at DrugInjuryWatch.com) According to Merck & Co., as of May…
-
May 2007 Mixed Verdict In Hormone Replacement Drug Trial: Victory For Wyeth; Loss For Pfizer
Plaintiff Simon Developed Breast Cancer After Using HRT Drugs Prempro, Premarin, And Provera (Posted by Tom Lamb at DrugInjuryWatch.com) On May 15, 2007 a Pennsylvania state court jury handed down a mixed verdict in…
-
Natrecor Safety Controversy Considered In Two May 2007 Medical Journal Articles
Is Natrecor An Example Of Why Dr. Steven Nissen Thinks That The FDA Is Dysfunctional And In Need Of Reform? (Posted by Tom Lamb at DrugInjuryWatch.com) Natrecor (nesiritide) is approved for the treatment of…
-
FDA Now Provides Emerging Drug Safety Information By Means Of Audio Broadcasts, Or Podcasts
Recent Subjects Have Been Drug Recalls Involving IBS Medication Zelnorm And Parkinson’s Drug Permax (Posted by Tom Lamb at DrugInjuryWatch.com) An April 20, 2007 FDA News item reminded doctors and other health care professionals…
